HCA Healthcare ( (HCA) ) has issued an update.
On April 25, 2025, HCA Healthcare announced its financial results for the first quarter of 2025, reporting revenues of $18.321 billion and a net income of $1.610 billion. The company declared a quarterly cash dividend of $0.72 per share, payable on June 30, 2025. The results showed a growth in same facility admissions and emergency room visits, although outpatient surgeries declined. HCA Healthcare also repurchased 7.762 million shares of its common stock during the quarter. The company reaffirmed its 2025 guidance, indicating confidence in its performance and the growing demand for healthcare services.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Neutral.
HCA Healthcare has strong revenue growth and cash flow generation, but it faces challenges with declining profit margins and high leverage due to negative equity. The stock’s technical indicators suggest weak momentum, though it is reasonably valued. The recent earnings call highlighted operational resilience and strong shareholder returns, contributing positively to the outlook.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
HCA Healthcare operates in the healthcare industry, managing 192 hospitals and around 2,500 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics across 20 states and the United Kingdom.
YTD Price Performance: 14.00%
Average Trading Volume: 1,677,718
Technical Sentiment Signal: Strong Sell
Current Market Cap: $84.06B
For a thorough assessment of HCA stock, go to TipRanks’ Stock Analysis page.